Discovery of 4,4′-Dipyridylsulfide Analogs as “Switchable Electrophiles” for Covalent Inhibition

• Published in: ACS chemical biology 2021-02, Vol.16 (2), p.264-269
• Main Authors: Ahn, Yeong-Chan, May, Valerie K, Bedford, Guy C, Tuley, Alfred A, Fast, Walter
• Format: Article
• Language: English
• ISSN: 1554-8929; 1554-8937
• DOI: 10.1021/acschembio.0c00890

Electrophilic heterocycles offer attractive features as covalent fragments for inhibitor and probe development. A focused library of heterocycles for which protonation can enhance reactivity (called “switchable electrophiles”) is screened for inhibition of the proposed drug target dimethylarginine dimethylaminohydrolase (DDAH). Several novel covalent fragments are identified: 4-chloroquinoline, 4-bromopyridazine, and 4,4-dipyridylsulfide. Mechanistic studies of DDAH inactivation by 4,4-dipyridylsulfide reveal selective covalent S-pyridinylation of the active-site Cys through catalysis by a neighboring Asp residue. Inactivation (k inact/K I = 0.33 M–1 s–1) proceeds with release of 4-thiopyridone (0.78 equiv), and structure–activity relationships reveal that the leaving group pK a can be modulated to tune reactivity. The use of a “switchable electrophile” strategy helps impart selectivity, even to fragment-sized modifiers. Identification of 4,4-dipyridylsulfide analogs as inactivators offers an easily tunable covalent fragment with multiple derivatization sites on both the leaving and staying groups.